2019. Apr

Correlation Between Vanishing White Matter Disease and Novel Heterozygous EIF2B3 Variants Using Next-Generation Sequencing: A Case Report.

Ann Rehabil Med. 2019

Hyun SE, Choi BS, Jang JH, Jeon I, Jang DH, Ryu JS.

Green Cross Genome Corporation I  Representative: KI CHANG SEOK   I   Business Registration No. 142-81-61687

107, Ihyeon-ro 30beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, 16924, Korea

Email. info.gcgenome@gccorp.com  I  Tel. +82 31-280-9939   I    Fax. +82 31-260-9087

©2020 by GC Genome.